HomePAR • ASX
add
Paradigm Biopharmaceuticals Ltd
Nakaraang pagsara
$0.41
Sakop ng araw
$0.41 - $0.43
Sakop ng taon
$0.17 - $0.66
Market cap
162.05M AUD
Average na Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 8.35K | — |
Gastos sa pagpapatakbo | 3.17M | -87.35% |
Net na kita | -2.96M | 88.16% |
Net profit margin | -35.47K | — |
Kita sa bawat share | — | — |
EBITDA | -3.14M | 87.47% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 24.78M | -26.15% |
Kabuuang asset | 35.36M | -21.50% |
Kabuuang sagutin | 1.30M | -88.42% |
Kabuuang equity | 34.06M | — |
Natitirang share | 389.43M | — |
Presyo para makapag-book | 4.56 | — |
Return on assets | -22.44% | — |
Return on capital | -23.18% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.96M | 88.16% |
Cash mula sa mga operasyon | -4.11M | 83.89% |
Cash mula sa pag-invest | 23.10K | 0.00% |
Cash mula sa financing | 7.56M | -46.59% |
Net change in cash | 3.48M | 130.54% |
Malayang cash flow | -1.92M | 87.41% |
Tungkol
Itinatag
2014
Website
